v3.24.3
Stock Based Compensation
9 Months Ended
Nov. 02, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation

10. Stock Based Compensation

As of November 2, 2024, there were 3,967,586 shares of common stock available for issuance under the Company’s 2022 Omnibus Incentive Plan.

Non-cash stock compensation expense is as follows:

 

 

(in thousands)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

November 2,

 

 

October 28,

 

 

November 2,

 

 

October 28,

 

Type of Non-Cash Stock Compensation

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Restricted stock unit grants (a)

 

$

11,698

 

 

$

11,599

 

 

$

32,469

 

 

$

32,143

 

Stock option grants (a)

 

 

5,065

 

 

 

5,417

 

 

 

14,673

 

 

 

14,615

 

Performance stock unit grants (a)

 

 

8,647

 

 

 

4,629

 

 

 

22,154

 

 

 

11,034

 

Total (b)

 

$

25,410

 

 

$

21,645

 

 

$

69,296

 

 

$

57,792

 

 

(a)
Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.
(b)
The amounts presented in the table above exclude taxes. For the three and nine month periods ended November 2, 2024, the tax benefit related to the Company’s non-cash stock compensation was approximately $4.4 million and $12.3 million, respectively. For the three and nine month periods ended October 28, 2023, the tax benefit related to the Company’s non-cash stock compensation was approximately $4.1 million and $10.9 million, respectively.

Stock Options

Stock option transactions during the nine month period ended November 2, 2024 are summarized as follows:

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price Per
Share

 

Options outstanding, February 3, 2024

 

 

1,356,258

 

 

$

197.90

 

Options granted

 

 

378,728

 

 

 

181.10

 

Options exercised (a)

 

 

(172,168

)

 

 

165.93

 

Options forfeited

 

 

(71,451

)

 

 

208.17

 

Options outstanding, November 2, 2024

 

 

1,491,367

 

 

 

196.83

 

 

(a)
Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $12.0 million.

The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of November 2, 2024:

 

 

Options

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Weighted
Average
Exercise
Price

 

 

Aggregate
Intrinsic
Value
(in millions)

 

Options vested and expected to vest

 

 

1,491,367

 

 

 

7.2

 

 

$

196.83

 

 

$

80.1

 

Options exercisable

 

 

732,110

 

 

 

5.6

 

 

$

202.38

 

 

$

38.6

 

 

The fair value of each stock option granted during the nine month period ended November 2, 2024 was estimated using the Black Scholes option pricing model using the following assumptions on a weighted average basis:

 

 

 

Nine Months Ended

 

 

 

November 2,

 

 

 

2024

Risk-free interest rate

 

 

4.7%

Expected volatility

 

 

42.2%

Expected life (years)

 

 

4.0

Contractual life (years)

 

 

10.0

Expected dividend yield

 

 

0%

Grant date fair value of options issued

 

$

69.52

 

The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. To evaluate its volatility factor, the Company uses the historical volatility of its stock price over the expected life of the options. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. The expected life of the options was estimated using historical exercise rates.

Restricted Stock Units

Restricted stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested awards outstanding, February 3, 2024

 

 

570,952

 

 

$

204.97

 

Awards granted

 

 

315,920

 

 

 

184.47

 

Awards vested (a)

 

 

(164,809

)

 

 

225.24

 

Awards forfeited

 

 

(48,605

)

 

 

194.98

 

Non-vested awards outstanding, November 2, 2024

 

 

673,458

 

 

 

191.11

 

 

(a)
Restricted stock units vested during the nine month period ended November 2, 2024 had a total intrinsic value of $31.3 million.

 

The fair value of each share of restricted stock granted during the nine month period ended November 2, 2024 was based upon the closing price of the Company’s common stock on the grant date.

Performance Stock Units

The Company grants performance-based restricted stock units to its senior executives. Vesting of the performance stock units granted in Fiscal 2021 is based on continued service and the achievement of pre-established adjusted EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year performance period. Vesting of the performance stock units granted in Fiscal 2022, Fiscal 2023, and Fiscal 2024 are based on continued service and the achievement of pre-established adjusted net income per share growth over a three-year performance period. Based on the Company’s achievement of these goals, each award may be earned up to 200% of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award.

Performance stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested awards outstanding, February 3, 2024

 

 

226,917

 

 

$

217.29

 

Awards granted

 

 

124,821

 

 

 

185.19

 

Awards vested (a)

 

 

(44,535

)

 

 

319.32

 

Awards forfeited

 

 

(11,820

)

 

 

216.38

 

Non-vested awards outstanding, November 2, 2024

 

 

295,383

 

 

 

188.38

 

 

(a)
Performance-based stock awards vested during the nine month period ended November 2, 2024 had a total intrinsic value of $10.1 million.